STEVEN RUTHS: Open Payments
NPI 1093748519 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,700 in 93 payments from 15 companies in 2025. Trend: 2023 $20,892 · 2024 $10,504 · 2025 $12,700
Speaker / faculty: $9,900Food & beverage: $2,573Travel & lodging: $227
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $11,142 |
| E.R. Squibb & Sons, L.L.C. | 9 | $510 |
| Teva Pharmaceuticals USA, Inc. | 6 | $331 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $205 |
| Almatica Pharma LLC | 5 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Alkermes, Inc. | 3 | $68 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Tris Pharma Inc | 2 | $45 |
Products named: VRAYLAR, COBENFY, AUSTEDO XR, CAPLYTA, TRINTELLIX, LOREEV XR, Auvelity, ARISTADA.
Industry payments across CA — which companies pay providers there.
